
Enable job alerts via email!
Generate a tailored resume in minutes
Land an interview and earn more. Learn more
A UK regulatory agency is seeking a Benefit Risk Evaluation Assessor to provide technical expertise on biological safety. This role involves collaborating with assessors to manage safety signals and advise on regulatory matters. Candidates should possess a degree in life sciences or engineering, and have relevant experience in healthcare or regulatory environments. The position offers a salary of £60,778 per annum and is crucial for patient safety evaluation and risk mitigation efforts.
Go back Medicines and Healthcare Products Regulatory Agency
The closing date is 11 January 2026
****TO APPLY FOR THIS ROLE, PLEASE ENSURE YOU CLICK THE LINK TO APPLY BUTTON (UNDER SUPPORTING LINKS). This will redirect you to the MHRA Website to submit your application. APPLICATIONS SUBMITTED VIA NHS JOBS WILL NOT BE ACCEPTED****
We have an exciting opportunity within the Benefit-Risk Evaluation group, a critical component of Safety and Surveillance. Reporting to the Biosafety, Nonclinical and Emerging Technologies TAU Head, the assessor will provide technical and regulatory expertise on biological safety matters to the Benefit Risk Evaluation Group, the Clinical Investigations Group and across MHRA.
The post holder is required to work collaboratively with other benefit risk assessors across the group to provide expert advice and direction to investigations on biological safety issues. Additionally, the post holder will also lead on the assessment of biological safety for clinical investigations and where appropriate, the development of guidance.
Key responsibilities:
The Medicines and Healthcare products Regulatory Agency enhance and improve the health of millions of people every day through the effective regulation of medicines and medical devices, underpinned by science and research.
The core purpose of Benefit Risk Evaluation is to deliver a robust assessment of potential safety signals using data from a range of sources along with technical, scientific, clinical and regulatory knowledge, and practical experience. The team conducts benefit-risk evaluations for medicines and medical device across a broad spectrum of therapeutic areas to guide actions that protect patient safety. The team is responsible for:
Signal detection of emerging safety issues
Evaluating the benefit risk of signals and developing effective and measurable risk mitigation measures
Using data and embracing new technologies to develop the evidence to support our actions and understand their impact
This post is subject to the Rehabilitation of Offenders Act (Exceptions Order) 1975 and as such it will be necessary for a submission for Disclosure to be made to the Disclosure and Barring Service (formerly known as CRB) to check for any previous criminal convictions.
Medicines and Healthcare Products Regulatory Agency